Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,304 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children.
Soto JA, Melo-González F, Gutierrez-Vera C, Schultz BM, Berríos-Rojas RV, Rivera-Pérez D, Piña-Iturbe A, Hoppe-Elsholz G, Duarte LF, Vázquez Y, Moreno-Tapia D, Ríos M, Palacios PA, Garcia-Betancourt R, Santibañez Á, Pacheco GA, Mendez C, Andrade CA, Silva PH, Diethelm-Varela B, Astudillo P, Calvo M, Cárdenas A, González M, Goldsack M, Gutiérrez V, Potin M, Schilling A, Tapia LI, Twele L, Villena R, Grifoni A, Sette A, Weiskopf D, Fasce RA, Fernández J, Mora J, Ramírez E, Gaete-Argel A, Acevedo ML, Valiente-Echeverría F, Soto-Rifo R, Retamal-Díaz A, Muñoz-Jofré N; PedCoronaVac03CL Study Group,; Meng X, Xin Q, Alarcón-Bustamante E, González-Aramundiz JV, Le Corre N, Álvarez-Figueroa MJ, González PA, Abarca K, Perret C, Carreño LJ, Bueno SM, Kalergis AM. Soto JA, et al. Among authors: meng x. mBio. 2022 Dec 20;13(6):e0131122. doi: 10.1128/mbio.01311-22. Epub 2022 Nov 16. mBio. 2022. PMID: 36383021 Free PMC article.
Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac®) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile.
Le Corre N, Abarca K, Astudillo P, Potin M, López S, Goldsack M, Valenzuela V, Schilling A, Gaete V, Rubio L, Calvo M, Twele L, González M, Fuentes D, Gutiérrez V, Reyes F, Tapia LI, Villena R, Retamal-Díaz A, Cárdenas A, Alarcón-Bustamante E, Meng X, Xin Q, González-Aramundiz JV, Álvarez-Figueroa MJ, González PA, Bueno SM, Soto JA, On Behalf Of The PedCoronaVac Cl Study Group, Perret C, Kalergis AM. Le Corre N, et al. Among authors: meng x. Vaccines (Basel). 2023 Sep 26;11(10):1526. doi: 10.3390/vaccines11101526. Vaccines (Basel). 2023. PMID: 37896930 Free PMC article.
Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.
Rivera-Pérez D, Méndez C, Diethelm-Varela B, Melo-González F, Vázquez Y, Meng X, Xin Q, Fasce RA, Fernández J, Mora J, Ramirez E, Acevedo ML, Valiente-Echeverría F, Soto-Rifo R, Grifoni A, Weiskopf D, Sette A, Astudillo P, Le Corre N, Abarca K, Perret C, González PA, Soto JA, Bueno SM, Kalergis AM. Rivera-Pérez D, et al. Among authors: meng x. Front Immunol. 2024 May 15;15:1372193. doi: 10.3389/fimmu.2024.1372193. eCollection 2024. Front Immunol. 2024. PMID: 38812507 Free PMC article.
Assessment of neutralizing antibody response as a correlate of protection against symptomatic SARS-CoV-2 infections after administration of two doses of the CoronaVac inactivated COVID-19 vaccine: A phase III randomized controlled trial.
Chen X, Meng X, Wu Q, Lim WW, Xin Q, Cowling BJ, Meng W, Yu H, Covasa DT. Chen X, et al. Among authors: meng x, meng w. J Infect. 2024 Dec;89(6):106315. doi: 10.1016/j.jinf.2024.106315. Epub 2024 Oct 16. J Infect. 2024. PMID: 39423875 Free article. Clinical Trial.
Lot-to-lot consistency, immunogenicity, and safety of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults: A randomized, double-blind, phase IV trial.
Zhu D, Hu Y, Jiang Z, Yang T, Chu K, Zhang H, Hu J, Meng X, Tan Z, Wu J, Lian X, Li C, Pan H. Zhu D, et al. Among authors: meng x. Hum Vaccin Immunother. 2022 Nov 30;18(6):2135929. doi: 10.1080/21645515.2022.2135929. Epub 2022 Nov 28. Hum Vaccin Immunother. 2022. PMID: 36441137 Free PMC article. Clinical Trial.
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.
Zhang Y, Qu JW, Zheng MN, Ding YX, Chen W, Ye SD, Li XY, Li YK, Liu Y, Zhu D, Jin CR, Wang L, Yang JY, Zhai Y, Wang EQ, Meng X. Zhang Y, et al. Among authors: meng x. Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047. Biomed Environ Sci. 2023. PMID: 37533385 Free article.
Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial.
Shu Y, Sun Z, Gao F, Huang Z, Meng X, Chen S, Shu Q, Wang L, Zhang H, Ying Z, Zhang J. Shu Y, et al. Among authors: meng x. Hum Vaccin Immunother. 2024 Dec 31;20(1):2402644. doi: 10.1080/21645515.2024.2402644. Epub 2024 Sep 23. Hum Vaccin Immunother. 2024. PMID: 39313857 Free PMC article. Clinical Trial.
Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study.
Song R, Zeng G, Yu J, Meng X, Chen X, Li J, Xie X, Lian X, Zhang Z, Cao Y, Yin W, Jin R. Song R, et al. Among authors: meng x. Emerg Microbes Infect. 2023 Dec;12(1):2212806. doi: 10.1080/22221751.2023.2212806. Emerg Microbes Infect. 2023. PMID: 37157134 Free PMC article. Clinical Trial.
15,304 results
You have reached the last available page of results. Please see the User Guide for more information.